LOPERAMIDE HYDROCHLORIDE
- Product NDC
- 68071-5331
- 11-digit product format
- 680715331
- Labeler code
- 68071
- Product ID
- 68071-5331_5dbd6b70-b4f8-3e03-e063-6294a90a3b22
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- LOPERAMIDE HYDROCHLORIDE
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA218122
- Marketing category
- ANDA
- Marketing start
- 2024-12-01
- Substance
- LOPERAMIDE HYDROCHLORIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Opioid Agonist [EPC], Opioid Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A218122-001 | LOPERAMIDE HYDROCHLORIDE | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2023-09-05 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A218122-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A218122-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2023-09-05 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A218122-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2023-09-05 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A218122-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2023-09-05 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A218122-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2023-09-05 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218122-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2023-09-05 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A218122-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2023-09-05 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A218122-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2023-09-05 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A218122-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2023-09-05 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A218122-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2023-09-05 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A218122-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2023-09-05 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A218122-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2023-09-05 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A218122-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2023-09-05 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A218122-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2023-09-05 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A218122-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2023-09-05 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A218122-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2023-09-05 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A218122-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2023-09-05 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A218122-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2023-09-05 | 8072bd15b7f6… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A218122-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2023-09-05 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A218122-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2023-09-05 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A218122-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2023-09-05 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A218122-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2023-09-05 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A218122-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2023-09-05 | 9b2671bbb829… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218122-001 | LOPERAMIDE HYDROCHLORIDE | 2MG | CAPSULE / ORAL | AB | 2023-09-05 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A218122-001 | AB | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A218122-001 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A218122-001 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A218122-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218122-001 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A218122-001 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A218122-001 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A218122-001 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A218122-001 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A218122-001 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A218122-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A218122-001 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A218122-001 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A218122-001 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A218122-001 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A218122-001 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A218122-001 | AB | 1 | 8072bd15b7f6… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A218122-001 | AB | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A218122-001 | AB | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A218122-001 | AB | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A218122-001 | AB | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A218122-001 | AB | 1 | 9b2671bbb829… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218122-001 | AB | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- LOPERAMIDE HYDROCHLORIDE
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LOPERAMIDE HYDROCHLORIDE | 2 mg/1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Loperamide HCl | LOPERAMIDE HCL | Direct_Rx | 59e1c4cf-17cc-13c9-e063-6294a90af61c | 2026-08-25 | Boxed warning, Warnings, Adverse reactions | 218122 ANDA218122 |
| LOPERAMIDE HYDROCHLORIDE | LOPERAMIDE HYDROCHLORIDE | REMEDYREPACK INC. | 3fdfc0e5-56a2-48a0-8ee6-390a194a29f3 | 2026-08-07 | Boxed warning, Warnings, Adverse reactions | 218122 ANDA218122 |
| LOPERAMIDE HYDROCHLORIDE | LOPERAMIDE HYDROCHLORIDE | Coupler LLC | 518bb0f0-88f2-1c95-e063-6294a90a722f | 2026-05-11 | Boxed warning, Warnings, Adverse reactions | 218122 ANDA218122 |
| LOPERAMIDE HYDROCHLORIDE | LOPERAMIDE HYDROCHLORIDE | Redpharm Drug | 3b0ac1a9-ffa6-9af6-e063-6294a90a2678 | 2025-12-02 | Boxed warning, Warnings, Adverse reactions | 218122 ANDA218122 |
| LOPERAMIDE HYDROCHLORIDE | LOPERAMIDE HYDROCHLORIDE | Major Pharmaceuticals | 1be585e2-ef49-4210-8a2d-22a326e4cc1b | 2025-09-11 | Boxed warning, Warnings, Adverse reactions | 218122 ANDA218122 |
| LOPERAMIDE HYDROCHLORIDE | LOPERAMIDE HYDROCHLORIDE | Bryant Ranch Prepack | 86d94804-ad01-4106-8f23-033f3a6bab9e | 2025-02-05 | Boxed warning, Warnings, Adverse reactions | 218122 ANDA218122 |
| LOPERAMIDE HYDROCHLORIDE | LOPERAMIDE HYDROCHLORIDE | A-S Medication Solutions | d572ecf7-ddc3-46fb-80a6-80b7b1b90a1b | 2024-10-25 | Boxed warning, Warnings, Adverse reactions | 218122 ANDA218122 |
| LOPERAMIDE HYDROCHLORIDE | LOPERAMIDE HYDROCHLORIDE | NorthStar Rx LLC | 858c2b62-98e6-46d7-9253-9b3a00040a4e | 2024-10-21 | Boxed warning, Warnings, Adverse reactions | 218122 ANDA218122 |
| LOPERAMIDE HYDROCHLORIDE | LOPERAMIDE HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | 1adb7a28-9dc6-3f8b-e063-6394a90a9335 | 2024-08-19 | Boxed warning, Warnings, Adverse reactions | 218122 ANDA218122 |
| LOPERAMIDE HYDROCHLORIDE | LOPERAMIDE HYDROCHLORIDE | Aurobindo Pharma Limited | 8d142533-4e87-4030-8fe9-4fc7473b0442 | 2023-09-11 | Boxed warning, Warnings, Adverse reactions | 218122 ANDA218122 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 68071-5331-2 | 68071533102 | 20 CAPSULE in 1 BOTTLE (68071-5331-2) | 20 capsule | 2026-10-12 | No | No | Current |
| 68071-5331-3 | 68071533103 | 30 CAPSULE in 1 BOTTLE (68071-5331-3) | 30 capsule | 2026-10-12 | No | No | Current |